WHO recognises MRC Cleanroom facility in Egypt

13-Jul-2022

Egypt-based Biogeneric Pharma's cleanroom facility, built by MRC Cleanrooms, is being recognised as a tech transfer recipient by the World Health Organisation

An MRC Cleanroom facility, built for long-term partner Biogeneric Pharma (BGP) based in Cairo Egypt, is being recognised as a tech transfer recipient by the WHO (World Health Organisation).

BGP will be the first technology transfer recipient of mRNA vaccine hub in Egypt for Africa & low- and middle-income countries. This huge accomplishment is the fruit of both process and facility excellence. Achieved through a focus on quality and consistency.

The groundbreaking project aims to assist low- and middle-income countries in manufacturing mRNA vaccines on a scale and according to international standards, with the aim of ending much of the reliance of African countries on vaccine manufacturers outside the continent.

The company received a WHO delegation headed by Mariângela Simão Assistant Director-General for Drug Access, Vaccines and Pharmaceuticals, who was impressed by the facility and its technical capabilities from both asset and personnel perspectives.

Sign up for your free email newsletter

"We hope that Biogeneric enjoys a long and successful business in this field and we look forward to further collaborations," MRC stated.

Featured Companies